A New Approach for Controlling Hemostasis During Canal Treatment
1 other identifier
interventional
60
1 country
1
Brief Summary
The persistence of blood may significantly affect final sealing with the persistence of microleakage (Zmener et al. 2008, Roggendorf et al. 2007). In cases of copious bleeding from root canals, calcium hydroxide, anesthetic solution with 1:50,000 epinephrine or ferric sulfate placed on a sterile paper cone, are recognized as effective hemostatic agents (Magnusson 1971, Kouri et al. 1969, Dannenberg 1974). The purpose of this study was to test the reduction of root canal bleeding in terms of significant percentage change for millimeters of blood in the canal at 2 different time points (baseline and after treatment with HybenX )
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 21, 2017
CompletedFirst Submitted
Initial submission to the registry
October 27, 2017
CompletedFirst Posted
Study publicly available on registry
November 8, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 22, 2017
CompletedResults Posted
Study results publicly available
March 13, 2019
CompletedMarch 26, 2019
March 1, 2019
4 months
October 27, 2017
January 18, 2019
March 13, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Change From Baseline in Root Canal Bleeding
After the root canal, shaping was performed a first sterile paper point was introduced in the root canal, up to the working length, to detect blood presence. The millimeters of blood on the paper point were measured with a caliber. After the intervention (HybenX or placebo) a second sterile paper point was introduced in the root canal, up to the working length, to detect the presence of blood according the previous criteria
Baseline and After Treatment (20 seconds)
Study Arms (2)
HybenX ®
EXPERIMENTAL1 cc of mixture of hydroxybenzenesulfonic acid (37%) and hydroxymethoxybenzene acids (23%), sulfuric acid (28%), and water (12%) for 20 sec
Control
PLACEBO COMPARATOR5 cc of sterile saline water for 20 sec
Interventions
The material was introduced inside the root canal using the pre-dosed syringe for 20 seconds with a sterile paper point with and up and down movement up to the working length. Finally, the canal was rinsed with sterile water using a syringe with a side-vented 30 G needle 1 mm shorter than the working length. A second sterile paper point was introduced in the root canal, up to the working length, for 10 seconds to detect the presence of blood and the millimeters of blood inside the root canal was measured again according the previous criteria.
The root canal was irrigated with sterile saline water with a syringe and a side-vented 30G needle activated for 20 seconds with a sterile paper point with and up and down movement up to the working length to ensure a flow of irrigant solution throughout the canal. Finally, the canal was rinsed with sterile water using a syringe with a side-vented 30 G needle 1 mm shorter than the working length. A second sterile paper point was introduced in the root canal, up to the working length, for 10 seconds to detect the presence of blood and the millimeters of blood inside the root canal was measured again according the previous criteria.
Eligibility Criteria
You may qualify if:
- patients aged between 20 and 60 years
- patients able and willing to sign a consent form,
- single-rooted teeth with necrotic pulp confirmed by electric vitality test
- healthy periodontium
- physiologic sulcus depth (\<3 mm)
- absence of bleeding on probing of the involved teeth.
You may not qualify if:
- patients with systemic diseases
- patients using anticoagulants in the last 30 days
- patients using antibiotics in the last 30 days
- patients using anti-inflammatory therapies in the last 30 days
- patients with allergy to sulfur in any form
- pregnancy.
- All subjects were informed of the nature and potential risks and benefits of their participation in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Dr Riccardo Pacelead
Study Sites (1)
AOUCareggi
Florence, 50100, Italy
Related Publications (10)
Pini-Prato G, Magnani C, Rotundo R. Nonsurgical Treatment of Peri-implantitis Using the Biofilm Decontamination Approach: A Case Report Study. Int J Periodontics Restorative Dent. 2016 May-Jun;36(3):383-91. doi: 10.11607/prd.2653.
PMID: 27100808BACKGROUNDLopez MA, Andreasi Bassi M, Confalone L, Silvestre F, Arcuri C. The treatment of peri-implant diseases: a new approach using hybenx(R) as a decontaminant for implant surface and oral tissues. Oral Implantol (Rome). 2016 Nov 13;9(3):106-114. doi: 10.11138/orl/2016.9.3.106. eCollection 2016 Jul-Sep.
PMID: 28042438BACKGROUNDPorter SR, Al-Johani K, Fedele S, Moles DR. Randomised controlled trial of the efficacy of HybenX in the symptomatic treatment of recurrent aphthous stomatitis. Oral Dis. 2009 Mar;15(2):155-61. doi: 10.1111/j.1601-0825.2008.01503.x.
PMID: 19207485BACKGROUNDZmener O, Pameijer CH, Serrano SA, Vidueira M, Macchi RL. Significance of moist root canal dentin with the use of methacrylate-based endodontic sealers: an in vitro coronal dye leakage study. J Endod. 2008 Jan;34(1):76-9. doi: 10.1016/j.joen.2007.10.012.
PMID: 18155498BACKGROUNDRoggendorf MJ, Ebert J, Petschelt A, Frankenberger R. Influence of moisture on the apical seal of root canal fillings with five different types of sealer. J Endod. 2007 Jan;33(1):31-3. doi: 10.1016/j.joen.2006.07.006. Epub 2006 Oct 13.
PMID: 17185125BACKGROUNDMagnusson B. Therapeutic pulpotomy in primary molars--clinical and histological follow-up. II. Zinc oxide-eugenol as wound dressing. Odontol Revy. 1971;22(1):45-54. No abstract available.
PMID: 5280515BACKGROUNDKouri EM, Matthews JL, Taylor PP. Epinephrine in pulpotomy. ASDC J Dent Child. 1969 Mar-Apr;36(2):123-8. No abstract available.
PMID: 4888301BACKGROUNDDannenberg JL. Pedodontic endodontics. Dent Clin North Am. 1974 Apr;18(2):367-77. No abstract available.
PMID: 4274315BACKGROUNDIsola G, Matarese G, Williams RC, Siciliano VI, Alibrandi A, Cordasco G, Ramaglia L. The effects of a desiccant agent in the treatment of chronic periodontitis: a randomized, controlled clinical trial. Clin Oral Investig. 2018 Mar;22(2):791-800. doi: 10.1007/s00784-017-2154-7. Epub 2017 Jun 17.
PMID: 28624914BACKGROUNDPini-Prato G, Magnani C, Rotundo R. Treatment of Acute Periodontal Abscesses Using the Biofilm Decontamination Approach: A Case Report Study. Int J Periodontics Restorative Dent. 2016 Jan-Feb;36(1):55-63. doi: 10.11607/prd.2557.
PMID: 26697553BACKGROUND
Results Point of Contact
- Title
- Dr. Riccardo Pace
- Organization
- AOUCareggi
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
October 27, 2017
First Posted
November 8, 2017
Study Start
April 1, 2017
Primary Completion
July 21, 2017
Study Completion
December 22, 2017
Last Updated
March 26, 2019
Results First Posted
March 13, 2019
Record last verified: 2019-03
Data Sharing
- IPD Sharing
- Will not share